Elise Schlissel Tremblay1, Jessica Ruiz2, Blair Dykeman3, Michele Maldonado4, Katharine Garvey1. 1. Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA. 2. Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA. 3. Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA. 4. Children's Hospital Primary Care Center, Social Work, Boston Children's Hospital, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: It is widely recognized that Type 1 Diabetes (T1D) outcomes are worse among Hispanic children; however, little is published about the perspectives of these patients and their caregivers. Our intent was to characterize the lived experience of Hispanic caregivers of children with T1D, focusing on the role of language and culture and their perspectives on current medical care and alternative care models. We studied Hispanic caregivers of patients (age 2-17 years) with T1D of greater than 6 months' duration. RESEARCH DESIGN AND METHODS: We completed semi-structured interviews and focus-groups of a purposive sample of 20 members of our population of interest. We developed a codebook and completed multidisciplinary consensus coding, then conducted iterative thematic analysis using qualitative software and discussion to generate themes. RESULTS: We gathered data from 20 Hispanic caregivers of T1D patients (11.37 ± 3.00 years old, 4.80 ± 2.84 years since diagnosis). 85% of caregivers were female, 80% preferred Spanish, and 15% were college-educated. Our analysis yielded 4 themes across the participants: (1) Culturally-based nutrition challenges, (2) Social isolation and lack of support for T1D care, (3) Hesitancy to fully embrace diabetes technology, and (4) Deferential views of care experience and providers. Overarching all of these themes was support for Hispanic group-based models of care tailored to address these concerns. CONCLUSIONS: The unique concerns among Hispanic caregivers of children with T1D suggest the importance of culturally tailored interventions to improve care. With successful implementation, such interventions could diminish widening disparities in healthcare outcomes.
OBJECTIVE: It is widely recognized that Type 1 Diabetes (T1D) outcomes are worse among Hispanic children; however, little is published about the perspectives of these patients and their caregivers. Our intent was to characterize the lived experience of Hispanic caregivers of children with T1D, focusing on the role of language and culture and their perspectives on current medical care and alternative care models. We studied Hispanic caregivers of patients (age 2-17 years) with T1D of greater than 6 months' duration. RESEARCH DESIGN AND METHODS: We completed semi-structured interviews and focus-groups of a purposive sample of 20 members of our population of interest. We developed a codebook and completed multidisciplinary consensus coding, then conducted iterative thematic analysis using qualitative software and discussion to generate themes. RESULTS: We gathered data from 20 Hispanic caregivers of T1D patients (11.37 ± 3.00 years old, 4.80 ± 2.84 years since diagnosis). 85% of caregivers were female, 80% preferred Spanish, and 15% were college-educated. Our analysis yielded 4 themes across the participants: (1) Culturally-based nutrition challenges, (2) Social isolation and lack of support for T1D care, (3) Hesitancy to fully embrace diabetes technology, and (4) Deferential views of care experience and providers. Overarching all of these themes was support for Hispanic group-based models of care tailored to address these concerns. CONCLUSIONS: The unique concerns among Hispanic caregivers of children with T1D suggest the importance of culturally tailored interventions to improve care. With successful implementation, such interventions could diminish widening disparities in healthcare outcomes.
Authors: Lital Reitblat; Robin Whittemore; Stuart A Weinzimer; William V Tamborlane; Lois S Sadler Journal: Diabetes Educ Date: 2016-05-09 Impact factor: 2.140
Authors: Maya I Ragavan; Kevin N Griffith; John D Cowden; Jeffrey D Colvin; Megan Bair-Merritt Journal: Acad Pediatr Date: 2019-12-17 Impact factor: 3.107
Authors: Russell M Viner; Billy White; Rakesh Amin; Catherine Peters; Amal Khanolkar; Deborah Christie; Peter C Hindmarsh Journal: Pediatr Diabetes Date: 2016-08-18 Impact factor: 4.866
Authors: Jessica M Valenzuela; Michael Seid; Beth Waitzfelder; Andrea M Anderson; Daniel P Beavers; Dana M Dabelea; Lawrence M Dolan; Giuseppina Imperatore; Santica Marcovina; Kristi Reynolds; Joyce Yi-Frazier; Elizabeth J Mayer-Davis Journal: J Pediatr Date: 2014-02-25 Impact factor: 4.406
Authors: Athena Philis-Tsimikas; Chris Walker; Lisa Rivard; Gregory Talavera; Joachim O F Reimann; Michelle Salmon; Rachel Araujo Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: Allison N Williams; Yolanda P Konopken; Colleen S Keller; Felipe Gonzalez Castro; Kimberly J Arcoleo; Estela Barraza; Donald L Patrick; Micah L Olson; Gabriel Q Shaibi Journal: Contemp Clin Trials Date: 2017-01-16 Impact factor: 2.261
Authors: L L Snyder; J M Stafford; D Dabelea; J Divers; G Imperatore; J Law; J M Lawrence; C Pihoker; E J Mayer-Davis Journal: Diabet Med Date: 2019-07-04 Impact factor: 4.213
Authors: Jean M Lawrence; Elizabeth J Mayer-Davis; Kristi Reynolds; Jennifer Beyer; David J Pettitt; Ralph B D'Agostino; Santica M Marcovina; Giuseppina Imperatore; Richard F Hamman Journal: Diabetes Care Date: 2009-03 Impact factor: 19.112
Authors: Andrew R Lavik; Osagie Ebekozien; Nudrat Noor; G Todd Alonso; Sarit Polsky; Scott M Blackman; Justin Chen; Sarah D Corathers; Carla Demeterco-Berggren; Mary Pat Gallagher; Margaret Greenfield; Ashley Garrity; Saketh Rompicherla; Robert Rapaport; Nana-Hawa Yayah Jones Journal: J Clin Endocrinol Metab Date: 2022-06-16 Impact factor: 6.134